Ambrobene solution for oral administration and inhalation 7.5 mg / ml vial. 100ml
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Germany
Package quantity, pcs
one
Structure
1 ml of solution for oral administration and inhalation contains:
Active ingredient: ambroxol hydrochloride 7.5 mg
Excipients: potassium sorbate, hydrochloric acid, purified water.
pharmachologic effect
Ambrobene belongs to chemical preparations that have an expectorant and phlegm-thinning effect.
The drug has a therapeutic effect in diseases with cough and difficult sputum discharge.
The main active ingredient is ambroxol.
Ambrobene also has an antioxidant effect: it neutralizes and removes damaging molecules called free radicals from the body.
The drug reduces the viscosity of phlegm and facilitates its outflow from the bronchi.
Ambrobene acts as follows:
the drug stimulates the production of enzymes in the bronchial mucosa, which break down the bonds between the substances that make up the phlegm
activates the formation of surfactant (a mixture of active substances that prevent adhesion of the alveoli of the lungs)
activates the function of the cilia of the bronchial mucosa, preventing them from sticking together.
Indications
For the treatment of chronic and acute respiratory diseases, in which there is sputum and its discharge from the respiratory tract is impaired: pneumonia, bronchitis with difficulty in sputum discharge, bronchial asthma, bronchiectasis.
Contraindications
individual intolerance to any component of the drug
peptic ulcer of the stomach and duodenum
epilepsy and convulsive syndrome
functional failure of the liver and kidneys
secretion of sputum in large quantities and impaired bronchial motility due to immobile cilia (due to the threat of sputum stagnation in the bronchi).
Side effects
From the immune system: infrequently - hypersensitivity reaction
frequency not established - anaphylactic reactions, incl.
rash, itching, urticaria, angioedema, anaphylactic shock.
From the nervous system: often - a violation of taste.
From the gastrointestinal tract: often - nausea
infrequently - dryness of the mucous membrane of the mouth and throat, vomiting, dyspepsia, abdominal pain, diarrhea.
Interaction
With the simultaneous use of ambroxol and antitussives, due to suppression of the cough reflex, secretion stagnation may occur.
Therefore, such combinations should be selected with care.
With the combined administration of ambroxol and the antibiotics amoxicillin, cefuroxime, erythromycin and doxycycline, the concentration of the latter in sputum and bronchial secretions increases.
The introduction of ambroxol (pH 5) should not be combined with the introduction of other solutions with a pH of more than 6.3, since the difference between the pH values ��of the solutions can lead to precipitation of the ambroxol base.
How to take, course of administration and dosage
The duration of treatment is selected individually, depending on the course of the disease.
It is not recommended to take Ambrobene without a doctor's prescription for more than 4-5 days.
The mucolytic effect of the drug is manifested when a large amount of liquid is taken.
Therefore, during treatment, it is recommended to drink plenty of fluids.
Inside, after meals, adding to water, juice or tea using the supplied measuring cup.
Children: up to 2 years old - 1 ml of the drug 2 times a day (15 mg of ambroxol per day)
from 2 to 6 years old - 1 ml of the drug 3 times a day (22.5 mg of ambroxol per day)
from 6 to 12 years old - 2 ml of the drug 2-3 times a day (30-45 mg of ambroxol per day).
Adults and children over 12 years of age: in the first 2-3 days of treatment - 4 ml of the drug 3 times a day (90 mg of Ambroxol per day).
If therapy is ineffective, adults can increase the dose to 8 ml of the drug 2 times a day (120 mg of ambroxol per day).
On the following days, you should take 4 ml of the drug 2 times a day (60 mg of ambroxol per day).
Inhalation
When using the drug Ambrobene in the form of inhalation, you can use any modern equipment (except for steam inhalers).
Before inhalation, pre
Name ENG
AMBROBENE
Clinical and pharmacological group
Mucolytic and expectorant drug
ATX code
Ambroxol
Dosage
7.5mg / ml x 100ml
Structure
1 ml of solution for oral administration and inhalation contains: Active ingredient: Ambroxol hydrochloride 7.5 mg
Excipients: potassium sorbate, hydrochloric acid, purified water.
Indications
Acute and chronic diseases of the respiratory tract, accompanied by a violation of the formation and discharge of sputum.
INN / Active ingredient
Ambroxol
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
Contraindications
Hypersensitivity to ambroxol or one of the excipients
pregnancy (I trimester).
Specifications
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Germany
Package quantity, pcs
one
Scope of application
Virology
Minimum age from
From birth
Way of introduction
Through the mouth
,
Through the respiratory tract
Vacation conditions
Without recipe
Volume, ml.
100 ml
Brand name
Ambrobene
Components
measuring glass
The amount of the dosage form in the primary package
100 ml
Primary packaging type
Dropper bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Expectorant mucolytic agent
Anatomical and therapeutic characteristics
R05CB06 Ambroxol
Dosage form
Solution for oral administration and inhalation
The target audience
Children
Expiration date in days
1825
Dosage (volume) of the substance in the preparation
ambroxol hydrochloride 7.5 mg
Package weight, g
one hundred
Mode of application
:
The duration of treatment is selected individually, depending on the course of the disease. It is not recommended to take Ambrobene without a doctor's prescription for more than 4-5 days. < br> The mucolytic effect of the drug is manifested when taking a large amount of liquid. Therefore, during treatment, it is recommended to drink plenty of fluids. < br> Inside, after meals, adding to water, juice or tea using the supplied measuring cup. < br> Children: under 2 years old - 1 ml of the drug 2 times a day (15 mg of ambroxol a day) from 2 to 6 years - 1 ml of the drug 3 times a day (22.5 mg of ambroxol per day) from 6 to 12 years old - 2 ml of the drug 2-3 times a day (30-45 mg of ambroxol per day). < br> Adults and children over 12 years of age: in the first 2-3 days of treatment - 4 ml of the drug 3 times a day (90 mg of Ambroxol per day).If therapy is ineffective, adults can increase the dose to 8 ml of the drug 2 times a day (120 mg ambroxol per day). On the following days, you should take 4 ml of the drug 2 times a day (60 mg of Ambroxol per day).
Information on technical characteristics, delivery set, country of manufacture